Diabetes Metab J.  2013 Oct;37(5):340-342. 10.4093/dmj.2013.37.5.340.

Diagnosing Diabetes with Hemoglobin A1c: Current Debates and Considerations for Anemic Patients

• Kim TH
• Choi SH

• KMID: 1965980
• DOI: http://doi.org/10.4093/dmj.2013.37.5.340

Abstract

No abstract available.

MeSH Terms

Hemoglobin A, Glycosylated*
Humans

Reference

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977–986.

2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837–853.

3. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359:1577–1589.

4. Simon D, Coignet MC, Thibult N, Senan C, Eschwege E. Comparison of glycosylated hemoglobin and fasting plasma glucose with two-hour post-load plasma glucose in the detection of diabetes mellitus. Am J Epidemiol. 1985; 122:589–593.

5. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32:1327–1334.

6. Executive summary: standards of medical care in diabetes: 2010. Diabetes Care. 2010; 33:Suppl 1. S4–S10.

7. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Geneva: World Health Organization;2011.

8. Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K. DETECT-2 Collaboration Writing Group. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care. 2011; 34:145–150.

9. Cho NH, Kim TH, Woo SJ, Park KH, Lim S, Cho YM, Park KS, Jang HC, Choi SH. Optimal HbA1c cutoff for detecting diabetic retinopathy. Acta Diabetol. Epub 2013 Jan 25. DOI: 10.1007/s00592-013-0452-3.

10. Malkani S, DeSilva T. Controversies on how diabetes is diagnosed. Curr Opin Endocrinol Diabetes Obes. 2012; 19:97–103.

11. Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care. 2011; 34:518–523.

12. Hare MJ, Shaw JE, Zimmet PZ. Current controversies in the use of haemoglobin A1c. J Intern Med. 2012; 271:227–236.

13. Carson AP, Reynolds K, Fonseca VA, Muntner P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care. 2010; 33:95–97.

14. Lorenzo C, Haffner SM. Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study. Diabetes Care. 2010; 33:335–337.

15. Choi SH, Kim TH, Lim S, Park KS, Jang HC, Cho NH. Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care. 2011; 34:944–949.

16. Kim C, Bullard KM, Herman WH, Beckles GL. Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2010; 33:780–785.

17. Son JI, Rhee SY, Woo JT, Hwang JK, Chin SO, Chon S, Oh S, Kim SW, Kim YS. Hemoglobin A1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects. Diabetes Metab J. 2013; 37:343–348.